Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Co. stock logo
CNMD
CONMED
$71.39
+0.9%
$76.66
$61.05
$138.47
$2.20B1.37585,358 shs61,735 shs
InMode Ltd. stock logo
INMD
InMode
$18.52
-0.7%
$19.86
$16.72
$48.25
$1.56B2.21.56 million shs518,651 shs
LivaNova PLC stock logo
LIVN
LivaNova
$62.78
+0.3%
$54.84
$42.75
$64.47
$3.40B0.92647,650 shs196,959 shs
Masimo Co. stock logo
MASI
Masimo
$136.62
-1.0%
$136.24
$75.22
$188.14
$7.23B0.99550,024 shs347,335 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Co. stock logo
CNMD
CONMED
-1.34%+5.34%-9.11%-15.11%-43.52%
InMode Ltd. stock logo
INMD
InMode
+5.73%+8.24%-4.60%-24.83%-44.64%
LivaNova PLC stock logo
LIVN
LivaNova
-2.42%+11.45%+16.05%+25.43%+31.84%
Masimo Co. stock logo
MASI
Masimo
+0.73%+1.32%-3.16%+2.40%-26.56%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Co. stock logo
CNMD
CONMED
4.9802 of 5 stars
3.42.02.54.32.81.74.4
InMode Ltd. stock logo
INMD
InMode
3.6606 of 5 stars
3.24.00.00.02.91.72.5
LivaNova PLC stock logo
LIVN
LivaNova
0.8213 of 5 stars
1.23.00.00.03.11.71.3
Masimo Co. stock logo
MASI
Masimo
3.5258 of 5 stars
1.22.00.04.22.42.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Co. stock logo
CNMD
CONMED
2.86
Moderate Buy$107.8651.08% Upside
InMode Ltd. stock logo
INMD
InMode
2.33
Hold$32.8077.11% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$66.205.45% Upside
Masimo Co. stock logo
MASI
Masimo
2.43
Hold$137.430.59% Upside

Current Analyst Ratings

Latest MASI, LIVN, CNMD, and INMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2024
CONMED Co. stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$107.00
5/3/2024
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/2/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$58.00 ➝ $66.00
5/2/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$75.00 ➝ $80.00
5/1/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
4/25/2024
CONMED Co. stock logo
CNMD
CONMED
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$115.00 ➝ $75.00
4/25/2024
CONMED Co. stock logo
CNMD
CONMED
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$98.00 ➝ $77.00
4/25/2024
CONMED Co. stock logo
CNMD
CONMED
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $95.00
4/25/2024
CONMED Co. stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$129.00 ➝ $107.00
4/15/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$148.00 ➝ $170.00
4/12/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $33.00
(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Co. stock logo
CNMD
CONMED
$1.24B1.77$6.02 per share11.85$27.13 per share2.63
InMode Ltd. stock logo
INMD
InMode
$492.05M3.16$2.32 per share7.98$6.68 per share2.77
LivaNova PLC stock logo
LIVN
LivaNova
$1.15B2.95$4.21 per share14.90$23.72 per share2.65
Masimo Co. stock logo
MASI
Masimo
$2.05B3.53$5.75 per share23.77$25.79 per share5.30

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Co. stock logo
CNMD
CONMED
$64.46M$2.6127.3512.960.686.53%13.78%4.86%7/24/2024 (Estimated)
InMode Ltd. stock logo
INMD
InMode
$197.92M$2.118.788.42N/A38.84%26.15%23.83%7/25/2024 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$0.60N/A18.74N/A-2.68%13.59%7.06%7/24/2024 (Estimated)
Masimo Co. stock logo
MASI
Masimo
$81.50M$1.5190.4835.76N/A3.98%13.77%5.98%5/7/2024 (Confirmed)

Latest MASI, LIVN, CNMD, and INMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Masimo Co. stock logo
MASI
Masimo
$0.71N/A-$0.71N/AN/AN/A  
5/1/2024Q1 2024
LivaNova PLC stock logo
LIVN
LivaNova
$0.45$0.73+$0.28$2.24$278.17 million$294.90 million      
4/24/2024Q1 2024
CONMED Co. stock logo
CNMD
CONMED
$0.74$0.79+$0.05$0.95$307.06 million$312.27 million      
2/27/2024Q4 2023
Masimo Co. stock logo
MASI
Masimo
$0.82$1.25+$0.43$1.87$545.69 million$548.90 million    
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    
2/13/202412/31/2023
InMode Ltd. stock logo
INMD
InMode
$0.66$0.71+$0.05$0.64$124.77 million$126.80 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Co. stock logo
CNMD
CONMED
$0.801.12%N/A30.65%N/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A

Latest MASI, LIVN, CNMD, and INMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2024
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201%3/14/20243/15/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Co. stock logo
CNMD
CONMED
1.16
2.18
1.08
InMode Ltd. stock logo
INMD
InMode
N/A
13.45
12.66
LivaNova PLC stock logo
LIVN
LivaNova
0.50
3.17
2.71
Masimo Co. stock logo
MASI
Masimo
0.64
2.18
1.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CONMED Co. stock logo
CNMD
CONMED
N/A
InMode Ltd. stock logo
INMD
InMode
68.04%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Masimo Co. stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
CONMED Co. stock logo
CNMD
CONMED
6.80%
InMode Ltd. stock logo
INMD
InMode
6.92%
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Masimo Co. stock logo
MASI
Masimo
9.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Co. stock logo
CNMD
CONMED
4,00030.80 million28.71 millionOptionable
InMode Ltd. stock logo
INMD
InMode
58183.98 million78.17 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.15 million54.05 millionOptionable
Masimo Co. stock logo
MASI
Masimo
5,20052.91 million47.78 millionOptionable

MASI, LIVN, CNMD, and INMD Headlines

SourceHeadline
FDA Clears Stork OTC Baby Monitoring SystemFDA Clears Stork OTC Baby Monitoring System
empr.com - May 6 at 10:18 PM
What Wall Street expects from Masimos earningsWhat Wall Street expects from Masimo's earnings
markets.businessinsider.com - May 6 at 10:18 PM
Will Apple Shake up the Medical Device Industry Again After FDA’s Recent Decision?Will Apple Shake up the Medical Device Industry Again After FDA’s Recent Decision?
mddionline.com - May 6 at 5:17 PM
Masimo Says Its Baby Monitor Stork Got FDA ClearanceMasimo Says Its Baby Monitor Stork Got FDA Clearance
markets.businessinsider.com - May 6 at 9:18 AM
Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring SystemMasimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
businesswire.com - May 6 at 8:00 AM
New York State Common Retirement Fund Has $5.55 Million Stock Position in Masimo Co. (NASDAQ:MASI)New York State Common Retirement Fund Has $5.55 Million Stock Position in Masimo Co. (NASDAQ:MASI)
marketbeat.com - May 5 at 5:13 AM
Masimo (MASI) Set to Announce Earnings on TuesdayMasimo (MASI) Set to Announce Earnings on Tuesday
americanbankingnews.com - May 5 at 5:08 AM
Masimo Leadership Mishandled Acquisition, Inventory, Suit SaysMasimo Leadership Mishandled Acquisition, Inventory, Suit Says
news.bloomberglaw.com - May 4 at 9:57 PM
Masimo Co. (NASDAQ:MASI) Shares Sold by California Public Employees Retirement SystemMasimo Co. (NASDAQ:MASI) Shares Sold by California Public Employees Retirement System
marketbeat.com - May 3 at 4:47 AM
Apple is behind in AI and killed its self-driving car project. What’s next?Apple is behind in AI and killed its self-driving car project. What’s next?
msn.com - May 2 at 10:28 AM
Apple Watch Ultra 3 — new reports says it’s coming this yearApple Watch Ultra 3 — new reports says it’s coming this year
msn.com - May 1 at 10:48 PM
Masimo’s Consumer Audio Brands Join The Specifi PlatformMasimo’s Consumer Audio Brands Join The Specifi Platform
twice.com - May 1 at 5:47 PM
Masimos billionaire CEO put shares on margin to get cash while keeping ownership ahead of proxy fightMasimo's billionaire CEO put shares on margin to get cash while keeping ownership ahead of proxy fight
cnbc.com - May 1 at 4:05 PM
Masimo Co. (NASDAQ:MASI) Director Craig B. Reynolds Sells 40,000 SharesMasimo Co. (NASDAQ:MASI) Director Craig B. Reynolds Sells 40,000 Shares
americanbankingnews.com - May 1 at 5:38 AM
Masimo Co. (NASDAQ:MASI) Director Sells $5,446,800.00 in StockMasimo Co. (NASDAQ:MASI) Director Sells $5,446,800.00 in Stock
insidertrades.com - May 1 at 4:44 AM
Remote Patient Monitoring (RPM) Market Big Money to be Made as Market Size Continues to SurgeRemote Patient Monitoring (RPM) Market Big Money to be Made as Market Size Continues to Surge
taiwannews.com.tw - May 1 at 2:46 AM
Are you an Apple Card user? Keep an eye out for an important emailAre you an Apple Card user? Keep an eye out for an important email
msn.com - April 30 at 4:45 PM
Masimo Insider Ups Holding During YearMasimo Insider Ups Holding During Year
finance.yahoo.com - April 30 at 4:45 PM
Masimo (MASI) Scheduled to Post Quarterly Earnings on TuesdayMasimo (MASI) Scheduled to Post Quarterly Earnings on Tuesday
marketbeat.com - April 30 at 11:28 AM
Masimo Co. (NASDAQ:MASI) Shares Purchased by abrdn plcMasimo Co. (NASDAQ:MASI) Shares Purchased by abrdn plc
marketbeat.com - April 30 at 4:46 AM
Apple Watch Series 9 vs. Series 8: Which model should you buy?Apple Watch Series 9 vs. Series 8: Which model should you buy?
msn.com - April 29 at 7:20 PM
‘Oops I Dropped The Lemon Trat’‘Oops I Dropped The Lemon Trat’
dailypioneer.com - April 27 at 3:21 PM
Masimo Corporation Common Stock (MASI)Masimo Corporation Common Stock (MASI)
nasdaq.com - April 27 at 12:20 AM
Apple Watch Series 9 Now Available on Apples Refurbished Store in U.S.Apple Watch Series 9 Now Available on Apple's Refurbished Store in U.S.
macrumors.com - April 26 at 8:55 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CONMED logo

CONMED

NYSE:CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
InMode logo

InMode

NASDAQ:INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Masimo logo

Masimo

NASDAQ:MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.